Jump to navigation
This is a list of United States Code sections, Statutes at Large, Public Laws, and Presidential Documents, which provide rulemaking authority for this CFR Part.
This list is taken from the Parallel Table of Authorities and Rules provided by GPO [Government Printing Office].
It is not guaranteed to be accurate or up-to-date, though we do refresh the database weekly. More limitations on accuracy are described at the GPO site.
§ 321 - Definitions; generally
§ 331 - Prohibited acts
§ 351 - Adulterated drugs and devices
§ 352 - Misbranded drugs and devices
§ 353 - Exemptions and consideration for certain drugs, devices, and biological products
§ 355 - New drugs
§ 356 - Expedited approval of drugs for serious or life-threatening diseases or conditions
§ 357 - Repealed. Pub. L. 105–115, title I, § 125(b)(1), Nov. 21, 1997, 111 Stat. 2325
§ 360 - Registration of producers of drugs or devices
§ 371 - Regulations and hearings
§ 374 - Inspection
§ 262 - Regulation of biological products
Title 21 published on 2015-12-03.
No entries appear in the Federal Register after this date, for 21 CFR Part 208.